Syndax Pharmaceuticals Statistics

Total Valuation

SNDX has a market cap or net worth of $1.40 billion. The enterprise value is $992.62 million.

Market Cap	1.40B
Enterprise Value	992.62M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, after market close.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

SNDX has 85.36 million shares outstanding. The number of shares has increased by 20.69% in one year.

Current Share Class	85.36M
Shares Outstanding	85.36M
Shares Change (YoY)	+20.69%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	0.37%
Owned by Institutions (%)	108.59%
Float	76.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	84.07
Forward PS	9.48
PB Ratio	3.83
P/TBV Ratio	3.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	62.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.99, with a Debt / Equity ratio of 0.00.

Current Ratio	6.99
Quick Ratio	6.92
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,726.95

Financial Efficiency

Return on equity (ROE) is -81.88% and return on invested capital (ROIC) is -55.13%.

Return on Equity (ROE)	-81.88%
Return on Assets (ROA)	-48.67%
Return on Invested Capital (ROIC)	-55.13%
Return on Capital Employed (ROCE)	-87.66%
Revenue Per Employee	$86,957
Profits Per Employee	-$1.61M
Employee Count	184
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.38% in the last 52 weeks. The beta is 0.90, so SNDX's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	-28.38%
50-Day Moving Average	14.06
200-Day Moving Average	18.38
Relative Strength Index (RSI)	68.27
Average Volume (20 Days)	2,585,861

Short Selling Information

The latest short interest is 22.20 million, so 26.01% of the outstanding shares have been sold short.

Short Interest	22.20M
Short Previous Month	22.38M
Short % of Shares Out	26.01%
Short % of Float	29.02%
Short Ratio (days to cover)	10.20

Income Statement

In the last 12 months, SNDX had revenue of $16.00 million and -$297.06 million in losses. Loss per share was -$3.62.

Revenue	16.00M
Gross Profit	-48.19M
Operating Income	-321.21M
Pretax Income	-264.08M
Net Income	-297.06M
EBITDA	-321.20M
EBIT	-321.21M
Loss Per Share	-$3.62

Full Income Statement

Balance Sheet

The company has $406.40 million in cash and $854,000 in debt, giving a net cash position of $405.54 million or $4.75 per share.

Cash & Cash Equivalents	406.40M
Total Debt	854,000
Net Cash	405.54M
Net Cash Per Share	$4.75
Equity (Book Value)	366.43M
Book Value Per Share	4.28
Working Capital	355.43M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-258.86M
Capital Expenditures	n/a
Free Cash Flow	-258.86M
FCF Per Share	-$3.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,007.58%
Pretax Margin	-1,856.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.69%
Shareholder Yield	-20.69%
Earnings Yield	-21.25%
FCF Yield	-18.51%

Dividend Details

Analyst Forecast

The average price target for SNDX is $36.20, which is 121.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$36.20
Price Target Difference	121.00%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SNDX has an Altman Z-Score of 11.36 and a Piotroski F-Score of 1.

Altman Z-Score	11.36
Piotroski F-Score	1